Skip to main content
. 2024 Jan 16;17(1):115. doi: 10.3390/ph17010115

Figure 4.

Figure 4

(a) Temporal trends in the annual proportion of antiretroviral drug resistance mutations among ART-experienced participants overall. (b) Distribution of sites in individuals with drug resistance mutation who experienced virologic failure. (c) Percentage and level of susceptibility to acquired drug resistance mutations.